ERIS LIFESCIENCES
|
The Current P/E Ratio of ERIS LIFESCIENCES is 28.76.
| Share Price | ₹1,384.0 | Aug 07,2026 |
| Market Cap | ₹19,182.2 Cr | |
| Earnings-TTM | ₹666.9 Cr | TTM-Consolidated Results |
| Price/Earnings | 28.76x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ERIS LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹19,182.2 Cr] as on Aug 07,2026
(/) Earnings [ ₹666.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.76x ]
Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay 28.76 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ERIS LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ERIS LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ERIS LIFESCIENCES
PE Ratio Performance Analysis for ERIS LIFESCIENCES
- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 30.11x.
- ERIS LIFESCIENCES 's operated at median p/e ratio of 23.11x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2025 at 54.83x.
- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 20.36x.
How does ERIS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ERIS LIFESCIENCES | 666.92 | 28.76 | 19,182.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.42 | 467,630.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 74.86 | 218,972.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 87.36 | 188,358.0 |
| CIPLA LTD | 3,364.84 | 35.34 | 118,916.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.87 | 97,824.0 |
| MANKIND PHARMA LTD | 2,055.11 | 49.01 | 100,730.0 |
| LUPIN LTD | 5,551.01 | 19.44 | 107,907.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.13 | 111,242.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.74 | 95,570.3 |
| LAURUS LABS LTD | 1,090.76 | 91.89 | 100,228.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ERIS LIFESCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.44x |
| Max industry PE | 91.89x |
| Median industry PE | 35.34x |
| Average industry PE | 45.80x |
You may also like the below Video Courses